Piramal Pharma
NSEI:PPLPHARMA
Rp 141,07
Rp0,00 (0,00%)
141,07 Rp
Rp0,00 (0,00%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

Rp0,19
Earnings Per Share
Rp61,76
Revenue Per Share
0,00%
Gross Margin %
Rp187,32 B
Market Cap
Rp32,14 B
Long-Term Debt
Earnings Per Share
Rp0,19
Revenue Per Share
Rp61,76
Gross Margin %
0,00%
Market Cap
Rp187,32 B
Long-Term Debt
Rp32,14 B

Financials

Year Year 2025 2024 2023 2022
EPS Earnings Per Share Rp0,68 Rp0,14 Rp-1,57 Rp3,19
Earnings Earnings Rp900,56M Rp185,21M Rp-1,87B Rp3,78B
RPS Revenue Per Share Rp69,10 Rp61,76 Rp59,34 Rp0,00
Revenue Revenue Rp91,51B Rp81,71B Rp70,82B Rp0,00M
OCF Operating Cash Flow Rp5,49B Rp10,05B Rp4,84B Rp0,00M
FCF Free Cash Flow Rp2,66B Rp2,93B Rp-4,61B Rp0,00M
OM Operating Margin 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share Rp0,00 Rp0,00 Rp0,00 Rp0,00
LT Debt Long-Term Debt Rp32,14B Rp24,84B Rp33,84B Rp26,22B
Sha. Stocks 1.324,35M 1.322,95M 1.193,32M 1.185,91M
×